Bruker Corp. Aktie
41,72 €
Deine Einschätzung
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -2,30 % | -10,87 % | 9,47 % | -24,67 % | 2,28 % | - | - |
| Omnicell Inc. | -0,46 % | -0,91 % | 10,15 % | 5,34 % | 11,86 % | -14,90 % | -55,71 % |
| Integer Hldg | 0,68 % | 1,38 % | 11,36 % | -46,35 % | 12,21 % | 10,53 % | 13,08 % |
| Healthequity Inc. | -1,35 % | -9,32 % | -8,75 % | -24,35 % | -6,41 % | 33,94 % | 15,87 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




